• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测缺血性心力衰竭患者合适的 ICD 治疗。

Prediction of appropriate ICD therapy in patients with ischemic heart failure.

机构信息

Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russian Federation.

出版信息

J Nucl Cardiol. 2022 Apr;29(2):680-691. doi: 10.1007/s12350-020-02321-y. Epub 2020 Aug 26.

DOI:10.1007/s12350-020-02321-y
PMID:32851586
Abstract

BACKGROUND

Previous studies show inconsistent results on the role of innervation imaging (with I-123-mIBG) and perfusion imaging in predicting appropriate ICD therapy (aICDth). These studies included patients with both dilated and ischemic cardiomyopathy. This study compared the ability of I-mIBG imaging along with perfusion imaging (using thallium-199) to predict aICDth in patients with ischemic heart failure (IHF) in relation to indication for ICD implantation (primary vs. secondary prevention of sudden cardiac death (SCD)).

METHODS

mIBG/thallium SPECT imaging were performed before ICD implantation in 80 patients with IHF: 49 candidates for primary and 31 for secondary SCD prevention.

RESULTS

During a mean follow-up of 18 months, the imaging results could not predict patients with appropriate ICD therapy among patients with ICD implants for primary SCD prevention. While in the secondary SCD prevention group, those who received a ICDth had significantly larger summed scores of regional perfusion and innervation impairment, but not higher heart-to-mediastinal mIBG ratio. The best results to predict aICDth were using mIBG summed score (cut-off point > 34%, sensitivity 72%, specificity 100%, AUC 0.909, P < 0.0001).

CONCLUSION

The prognostic value of innervation and perfusion imaging in patients with IHF differ based on indication for ICD implantation (primary vs. secondary prevention of SCD).

摘要

背景

先前的研究表明,在预测适当的 ICD 治疗(aICDth)方面,神经成像(使用 I-123-mIBG)和灌注成像的作用结果不一致。这些研究包括扩张型和缺血性心肌病患者。本研究比较了 I-mIBG 成像与灌注成像(使用铊-199)在缺血性心力衰竭(IHF)患者中的作用,以评估其与 ICD 植入指征(心脏性猝死(SCD)的一级预防与二级预防)的关系,以预测 aICDth。

方法

在 80 例 IHF 患者植入 ICD 前进行 mIBG/铊 SPECT 成像:49 例为一级预防,31 例为二级预防 SCD。

结果

在平均 18 个月的随访中,成像结果无法预测一级预防 SCD 的 ICD 植入患者中的适当 ICD 治疗患者。而在二级预防 SCD 组中,那些接受 ICDth 的患者的区域灌注和神经支配损伤的总和评分显著更高,但心脏与纵隔间 mIBG 比值没有更高。预测 aICDth 的最佳结果是使用 mIBG 总和评分(截断值>34%,灵敏度 72%,特异性 100%,AUC 0.909,P<0.0001)。

结论

在 IHF 患者中,神经和灌注成像的预后价值根据 ICD 植入的指征(一级预防与二级预防 SCD)而不同。

相似文献

1
Prediction of appropriate ICD therapy in patients with ischemic heart failure.预测缺血性心力衰竭患者合适的 ICD 治疗。
J Nucl Cardiol. 2022 Apr;29(2):680-691. doi: 10.1007/s12350-020-02321-y. Epub 2020 Aug 26.
2
Role of cardiac I-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD.心脏 I-mIBG 成像在预测 ICD 稳定慢性心力衰竭患者心律失常事件中的作用。
J Nucl Cardiol. 2019 Aug;26(4):1188-1196. doi: 10.1007/s12350-018-1258-z. Epub 2018 Mar 28.
3
Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.123 碘-间位碘苄胍心肌交感神经显像预测植入式心脏复律除颤器患者的室性心律失常。
J Am Coll Cardiol. 2010 Jun 15;55(24):2769-77. doi: 10.1016/j.jacc.2009.12.066.
4
Cardiac I-mIBG scintigraphy is associated with freedom of appropriate ICD therapy in stable chronic heart failure patients.心脏 I-mIBG 闪烁显像术与稳定的慢性心力衰竭患者适当的 ICD 治疗的自由相关。
Int J Cardiol. 2017 Dec 1;248:403-408. doi: 10.1016/j.ijcard.2017.08.003. Epub 2017 Aug 25.
5
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.心脏碘-123 -metaiodobenzylguanidine 显像预测心力衰竭患者接受植入式心脏复律除颤器一级预防后的室性心律失常。
Heart. 2012 Sep;98(18):1359-65. doi: 10.1136/heartjnl-2012-302321.
6
A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.基于简化壁的模型评估心脏 123I-MIBG 和静息 99mTc-甲氧基异丁基异腈 SPECT 评估区域神经支配/灌注不匹配,以预测缺血性心力衰竭中的心律失常事件。
Eur Heart J Cardiovasc Imaging. 2022 Aug 22;23(9):1201-1209. doi: 10.1093/ehjci/jeab132.
7
Quality and utility of [I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator.[I]I-间碘苄胍心脏 SPECT 显像在适合植入式心脏复律除颤器的非糖尿病心肌梗死后心力衰竭患者中的质量和效用。
Ann Nucl Med. 2021 Aug;35(8):916-926. doi: 10.1007/s12149-021-01628-1. Epub 2021 May 23.
8
Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.在适合植入植入式心脏除颤器的收缩功能障碍患者中,使用123I-间碘苄胍成像预测风险与预测潜在生存获益:来自前瞻性ADMIRE-HF研究的数据分析。
Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.114.003110.
9
The prognostic value of I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review.I-间碘苄胍 SPECT 心脏显像对心力衰竭患者预后价值的系统评价。
J Nucl Cardiol. 2022 Aug;29(4):1799-1809. doi: 10.1007/s12350-020-02501-w. Epub 2021 Jan 13.
10
The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.ADMIRE-HF风险评分在预测心力衰竭患者严重心律失常事件中的效用:心脏123I-间碘苄胍闪烁扫描术的增量预后价值
J Nucl Cardiol. 2014 Aug;21(4):756-62; quiz 753-55, 763-5. doi: 10.1007/s12350-014-9919-z.

引用本文的文献

1
Predicting postinfarct ventricular tachycardia by integrating cardiac MRI and advanced computational reentrant pathway analysis.通过整合心脏 MRI 和先进的复发性通路分析来预测心肌梗死后室性心动过速。
Heart Rhythm. 2024 Oct;21(10):1962-1969. doi: 10.1016/j.hrthm.2024.04.077. Epub 2024 Apr 24.
2
Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options.缺血性心肌病:流行病学、病理生理学、结局和治疗选择。
Heart Fail Rev. 2024 Jan;29(1):287-299. doi: 10.1007/s10741-023-10377-4. Epub 2023 Dec 16.
3
Optimal Protocol and Clinical Usefulness of I-MIBG Cardiac Scintigraphy for Differentiation of Parkinson's Disease and Dementia with Lewy Body from Non-Parkinson's Diseases.

本文引用的文献

1
Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements.近年来靶向去甲肾上腺素转运体的放射性示踪剂的研究进展:结构发展和放射性标记的改进。
J Neural Transm (Vienna). 2020 Jun;127(6):851-873. doi: 10.1007/s00702-020-02180-4. Epub 2020 Apr 9.
2
Prognostic value of cardiac metaiodobenzylguanidine imaging and QRS duration in implantable cardioverter defibrillator patients with and without heart failure.心脏 ^123I-间位碘代苄胍显像和 QRS 持续时间对心力衰竭和非心力衰竭植入型心脏复律除颤器患者的预后价值。
Int J Cardiol. 2019 Dec 1;296:164-171. doi: 10.1016/j.ijcard.2019.07.068. Epub 2019 Jul 23.
3
用于鉴别帕金森病、路易体痴呆与非帕金森病的碘-间碘苄胍心肌闪烁显像的最佳方案及临床应用价值
Nucl Med Mol Imaging. 2023 Jun;57(3):145-154. doi: 10.1007/s13139-023-00790-w. Epub 2023 Mar 7.
4
The value of cardiac sympathetic activity and mechanical dyssynchrony as cardiac resynchronization therapy response predictors: comparison between patients with ischemic and non-ischemic heart failure.心脏交感神经活动和机械性不同步作为心脏再同步治疗反应预测指标的价值:缺血性和非缺血性心力衰竭患者的比较
J Nucl Cardiol. 2023 Feb;30(1):371-382. doi: 10.1007/s12350-022-03046-w. Epub 2022 Jul 14.
5
Cardiac I-IBG Imaging in Heart Failure.心力衰竭中的心脏碘-123间碘苄胍显像
Pharmaceuticals (Basel). 2022 May 25;15(6):656. doi: 10.3390/ph15060656.
6
Cardiac I-mIBG scintigraphy for prediction of catheter ablation outcome in patients with atrial fibrillation.心脏 I-mIBG 闪烁显像术预测心房颤动患者导管消融治疗的效果。
J Nucl Cardiol. 2022 Oct;29(5):2220-2231. doi: 10.1007/s12350-021-02658-y. Epub 2021 May 27.
7
The prognostic value of I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review.I-间碘苄胍 SPECT 心脏显像对心力衰竭患者预后价值的系统评价。
J Nucl Cardiol. 2022 Aug;29(4):1799-1809. doi: 10.1007/s12350-020-02501-w. Epub 2021 Jan 13.
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Circulation. 2018 Sep 25;138(13):e210-e271. doi: 10.1161/CIR.0000000000000548.
4
Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial.心血管磁共振指导的轻至中度左心室收缩功能障碍管理(CMR GUIDE):一项随机对照试验的研究方案
Ann Noninvasive Electrocardiol. 2017 Jul;22(4). doi: 10.1111/anec.12420. Epub 2017 Jan 24.
5
Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.评估潜在病因和心脏交感神经支配以识别心脏性死亡高危患者。
J Nucl Med. 2001 Dec;42(12):1757-67.
6
[Technology for the production of 199Tl by the 197Au(alpha, 2n) reaction].[通过¹⁹⁷Au(α, 2n)反应生产¹⁹⁹Tl的技术]
Radiobiol Radiother (Berl). 1987;28(6):827-30.